MedTrace Logo

Prognosis of Type 2 Diabetic Patients

NCT01426685 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1880

Last updated 2019-04-19

No results posted yet for this study

Summary

The study will include 1200 patients with type 2 diabetes and angiographically documented coronary artery disease and 600 matched non-diabetic patients without type 2 diabetes. Extensive traditional and novel risk marker tests are performed for the patients and they will be followed-up for 5 years. Sudden cardiac death is the main outcome measure and various other endpoints are secondary endpoints. As a substudy, 120 diabetic patients and 120 non-diabetic patients will undergo exercise training with home monitoring to assess the effects of exercise training on risk profiles.

Conditions

  • Cardiovascular Risk Assessment

Sponsors & Collaborators

  • The Finnish Funding Agency for Technology and Innovation (TEKES)

    collaborator OTHER_GOV

  • University of Oulu

    lead OTHER

Principal Investigators

  • Heikki V Huikuri, MD · University of Oulu

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01426685 on ClinicalTrials.gov